Medical Information Only. Consult your healthcare provider before enrolling in any clinical trial.
Georgia: below-average open trial sites
1,657 of 5,195 in-state trials are recruiting (32%); below the 37% national average by 5 percentage points.
According to ClinicalTrials.gov-derived indexes, Georgia sits in the upper quartile of US states by in-state trial count (#13 of 52 states by registered in-state trial count).
Georgia: 5,195 US clinical trials with in-state sites, 1,657 recruiting.
Georgia has 5,195 registered US clinical trials with a study site in-state, 1,657 of them currently recruiting (below the 37% national average by 5 percentage points). 1,434 of these trials are in Phase 3 (late-stage) and 1,331 in Phase 2. The most frequently studied condition in Georgia is HIV Infections, with 94 linked trials.
Upper-quartile research density
Georgia sits in the upper quartile by in-state trial count. Open share is below the 37% national average by 5 percentage points - denser than most states, still short of the top-decile research hubs.
Below-average open enrollment
Georgia still shows 1,657 recruiting of 5,195 in-state trials (32% open), but below the 37% national average by 5 percentage points, so archived statuses weigh heavier than the national baseline.
- 32%
- open (below national share)
- 1,657
- still recruiting despite cool share
- 1,331
- Phase 2 rows in this footprint
- 94
- top: HIV Infections
Recruiting share is below the 37% national average by 5 percentage points. Counts include every study with at least one recorded site in the state. Registry reference only, not medical advice.
Georgia vs all states by indexed in-state trial count
Where this state's ClinicalTrials.gov site count sits among every state with at least one listed trial (coverage density, not care quality)
5,195 Top 25% more indexed trials than 75% of 52 states
States, banded by indexed in-state trial count
Each bar is a band; taller bars hold more states. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov · 2026-08-08
Key findings
What ClinicalTrials.gov does not surface for Georgia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Georgia open-enrollment share sits below the national baseline.
1,657 of 5,195 in-state trials (31.9%) are recruiting, against 37% nationally (-5.1 percentage points). Counts include every study with at least one recorded site in the state.
-
Atlanta dominates Georgia's trial geography.
Atlanta lists 3,400 of 5,195 in-state trials (65.4%) across 1,152 named facilities. Cities need five or more listed trials to appear here; locations are as filed by sponsors.
-
HIV Infections is the most-studied condition in Georgia.
94 of 5,195 in-state trials (1.8%) list HIV Infections. That is a local concentration figure, not a national disease ranking.
-
Georgia sponsorship is fragmented across many organizations.
Emory University appears on 411 of 5,195 in-state trials (7.9%). Sponsor identity is as filed on ClinicalTrials.gov.
-
2,347 Georgia trials carry a completed status.
2,347 of 5,195 (45.2%) are completed. The open share above is the remainder that still lists recruiting.
By Status
| Status | Trial count |
|---|---|
| Completed | 2,347 |
| Recruiting | 1,657 |
| Active | 1,191 |
By Phase
| Phase | Trial count |
|---|---|
| Phase 3 | 1,434 |
| Phase 2 | 1,331 |
| NA | 915 |
| Phase 1 | 673 |
| Phase 4 | 259 |
| Early Phase 1 | 20 |
Top Conditions
Top Sponsors
Where trials run in Georgia
Atlanta carries 3,400 of Georgia's 5,195 indexed trials (65%) across 1,152 named sites, ahead of Augusta at 523. 8 cities clear five listed trials, together naming 2,060 distinct sites.
| City | Trials | Listed sites |
|---|---|---|
| Atlanta | 3,400 | 1,152 |
| Augusta | 523 | 189 |
| Decatur | 361 | 173 |
| Marietta | 284 | 152 |
| Savannah | 231 | 131 |
| Columbus | 152 | 104 |
| Macon | 143 | 92 |
| Athens | 131 | 67 |
Distinct trials and named sites per city, as filed with ClinicalTrials.gov; cities under five trials omitted. Vintage 2026-08-08.
Recruiting-slot high
Georgia lists 1,657 recruiting trials (p78 by absolute open slots).
Georgia: absolute recruiting slots sit high among states
Geography is concentrated: Atlanta alone accounts for 65% of Georgia's indexed trials (3,400 of 5,195), with Augusta a distant second at 523.
Phase mix: 1,434 Phase 3 vs 1,331 Phase 2 (balanced across stages).
Top condition: HIV Infections (94 trials); top sponsor Emory University (411).
high-volume · mid-open figures (5,195 trials · 32% open) describe registry geography under the recruiting-slot high read, not clinic capacity or protocol fit. Confirm status on ClinicalTrials.gov before acting.
States near Georgia on absolute recruiting slots
Cross-state peers under the recruiting-slot high read (high-volume · mid-open), not the same-state browse list.
Similar high-volume hubs (± open share)
- Michigan · 4,790 trials · 34% recruiting
- Arizona · 5,607 trials · 30% recruiting
- North Carolina · 5,625 trials · 33% recruiting
- Minnesota · 4,506 trials · 36% recruiting
- Alabama · 4,168 trials · 29% recruiting
Similar mid-open peers (± trial volume)
- Kentucky · 32% recruiting · 2,183 trials
- Connecticut · 32% recruiting · 3,531 trials
- Vermont · 31% recruiting · 191 trials
- District of Columbia · 31% recruiting · 2,316 trials
- Colorado · 31% recruiting · 5,273 trials